11676

Insider Trading Report: Oracle Corp (ORCL)

Alison Fairhead, a director at Oracle Corp (ORCL), recently added 1,286 shares. The buy increased her stake by nearly 5.7 percent, and came to a total purchase price of just under $110,000. The director has been a prior buyer of shares back in March, picking up 10,242 shares for just under $689,000, and at a purchase price about 35 percent lower compared to where shares trade today. Otherwise, company insiders at the tech company have largely been sellers. Company insiders still own ...
Read More About This
|
11678

Unusual Options Activity: Ginkgo Bioworks Holdings (DNA)

Shares of biotech firm Ginkgo Bioworks Holdings (DNA) suffered a double-digit loss on Tuesday following a short-seller issuing a report questioning the company’s revenue sources. However, one trader sees shares shaking off the fear and moving higher. That’s based on the March $14 calls. With 161 days to trade, nearly 4,600 contracts traded, a 32-fold rise in volume from the prior open interest of 144. The buyer of the call paid $1.28 for the trade. The trade was made as shares were ...
Read More About This
|
11666

This High Profit-Margin Business Promises Big Growth

Software companies remain one of the best places for tech investors. It doesn’t require physical facilities to manufacture hardware, and a piece of software can be copied endlessly with little extra cost. That creates high profit margins. Today, software companies that offer data and analytic services can best use a recurring revenue model to create steady and growing cash flows as well. That’s a particularly attractive space for investors in tech today. One clear winner in the space is Palantir Technologies (PLTR) ...
Read More About This
|
11668

Insider Trading Report: Cheniere Energy Partners (CQP)

Blackstone Holdings III, a major holder of Cheniere Energy Partners (CQP), recently added 44,517 shares to their holdings. The buy increased the firm’s stake by 0.34 percent, and came to a total price of just over $1.8 million. Other major owners have also been buyers in the past few weeks, with the last insider sales occurring back in March with a massive 2.3 million share sale. The last activity from a non-major holder came from a director sale back in late ...
Read More About This
|
11670

Unusual Options Activity: Tesla Motors (TSLA)

Shares of electric carmaker Tesla Motors (TSLA) have been trending higher in recent weeks, aided by a report that the company has continued full production amid a global chip shortage. One trader sees shares moving higher in the coming weeks. That’s based on the October 22 $830 calls. With 15 days until expiration, over 12,175 contracts traded against a prior open interest of 449, for a 27-fold rise in volume. The buyer of the calls paid $10.08. Shares last traded around $780, ...
Read More About This
|
11657

Combining Two Top Tech Trends Can Lead to Bigger Profits

Investors are already aware of the top trends likely to produce trillions of dollars in wealth over the next decade. With markets having a classic autumn selloff from overpriced levels, some companies are looking ahead to that future. The best way to grow for many firms right now is to acquire smaller and faster-growing companies, particularly when those firms provide access to a new market for existing products. That may be the case with Qualcomm (QCOM). The wireless chipmaker has partnered ...
Read More About This
|
11659

Insider Trading Report: Compass Diversified Holdings (CODI)

Sarah McCoy, an executive at Compass Diversified Holdings (COI), recently picked up 3,164 shares. The buy increased her stake by nearly 15 percent, and came to a total cost of just over $89,000. This follows on a number of other insider buys over the past two months from a number of company insiders. On the sell side, only a major holder of shares has been selling shares over the past year. Overall, company insiders own over 15 percent of shares. Shares of ...
Read More About This
|
11661

Unusual Options Activity: Merck & Co (MRK)

Shares of pharmaceutical giant Merck (MRK) recently jumped higher on news of a Covid drug that could substantially reduce hospitalizations. One trader sees the trend continuing. That’s based on the November $100 calls. With 44 days on the trade, over 9,850 contracts traded against a prior open interest of 249, for a 40-fold rise in volume. The buyer of the calls paid $0.29 to make the trade. Even with the recent jump in price, shares are now only up about 5 percent ...
Read More About This
|